East Java Governor Khofifah Supports Acceleration Of Red And White Vaccine Clinical Trials

East Java Governor Khofifah Indar Parawansa while attending the 67th University of Langga (Unair) Anniversary Open Session, Tuesday, November 9 (Photo: Antara)

JAKARTA - East Java Governor Khofifah Indar Parawansa expressed his readiness to support the process of accelerating the clinical trial of the Red and White Vaccine made by Airlangga University starting from the first stage to the third stage.

Khofifah, while attending the Open Session of the 67th Anniversary of Airlangga University (Unair) in Surabaya, Tuesday, explained that currently, the implementation of the Red and White Vaccine clinical trial is still waiting for permission from the Food and Drug Supervisory Agency (BPOM).

The cooperation will be carried out by three parties consisting of Unair, PT Biotis Pharmaceuticals Indonesia, and the Dr. Soetomo Regional General Hospital (RSUD) in Surabaya.

The Chairperson of the Unair Alumni Association (IKA) said that so far there have been quite a few who have registered as volunteers for vaccine clinical trials.

"So, the place for clinical trials for volunteers is at Dr. Soetomo Hospital, so that we are also part of the acceleration of the implementation of the first, second and third stage of the Red and White Vaccine clinical trial", said Khofifah. 

The first female governor in East Java hopes that all parties can provide enthusiasm for the vaccine development process, especially tomorrow to coincide with November 10.

"As the Chair of the Unair Alumni Association, I am proud of Unair who has given the best offering for this country to provide protection and safety to all Indonesian people", he said.

"I reiterate that I will be the one who stands at the forefront of pushing for the success of the first, second, and third phase of vaccine clinical trials", added Khofifah.

Meanwhile, Unair Chancellor Prof Muhammad Nasih emphasized that the Red and White Vaccine is Unair's contribution to Indonesia.

Unair has handed over the Red and White Vaccine seeds to PT Biotis Pharmaceutical Indonesia for further clinical trials.

"Because we have conveyed the vaccine seeds to PT Biotis, the next stage is production on a pilot-scale", said Prof. Nasih.